Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
I'm PortAI, I can summarize articles.
Scinai Immunotherapeutics announced the resignation of two board members and plans to replace its accounting firm, PwC, with Ziv Haft to reduce costs. These changes are part of the company's financial recovery efforts, facing challenges like negative cash flows and high debt levels. The stock is rated Neutral by TipRanks' AI Analyst, with moderate market confidence and attractive valuation for value investors.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments